Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity
The product is primarily used for the short-term treatment of scurvy in adult and paediatric patients aged 5 months and older for whom oral administration is not possible, insufficient or contraindicated The post Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity appeared first on Express Pharma.
Read Full Article
Pharma Tech
Roche commits $750m to double Oregon-based US manufacturing capacity
Roche's Oregon fill-finish site will produce both autoinjectors and pre-filled syringes – serving its pipeline and portfolio.
Read Full Article
Pharma Tech
Eli Lilly’s weekly insulin jab Onswik set for NHS use if approved
Lilly’s drug could cut the number of injections each patient needs by 85%.
Read Full Article
Pharma Tech
WellSpan and Johns Hopkins renew partnership for advanced cancer care access
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration to widen access to advanced care throughout central Pennsylvania, US.
Read Full Article
Pharma Tech
Charles River and MVC to develop enterovirus vaccine
Charles River Laboratories International and MVC have entered a collaboration to support the characterisation, along with validation of the virus seed bank for the latter’s next-generation multivalent enterovirus vaccine.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Aug 21, 2026, 12:30 PM
Leads Biolabs Reports NMPA NDA Acceptance for Opamtistomig in Previously Treated Advanced EP-NEC
Shots: Ref: PRNewswire | Image: Leads Biolabs | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Leads Biolabs Reports NMPA NDA Acceptance for Opamtistomig in Previously Treated Advanced EP-NEC appeared first on PharmaShots.
Express Pharma
Aug 21, 2026, 11:39 AM
Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity
The product is primarily used for the short-term treatment of scurvy in adult and paediatric patients aged 5 months and older for whom oral administration is not possible, insufficient or contraindicated The post Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity appeared first on Express Pharma.
PharmaShots
Aug 21, 2026, 11:30 AM
IntraGel Therapeutics and UroGen Pharma Ink Strategic Collaboration & Investment to Advance TumoCure & Expand Sustained-Release Oncology Pipeline
Shots: Ref: PRNewswire | Image: IntraGel Therapeutics and UroGen Pharma | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect@pharmashots.com The post IntraGel Therapeutics and UroGen Pharma Ink Strategic Collaboration & Investment to Advance TumoCure & Expand Sustained-Release Oncology Pipeline appeared first on PharmaShots.
Pharma Tech
Aug 21, 2026, 10:59 AM
Roche commits $750m to double Oregon-based US manufacturing capacity
Roche's Oregon fill-finish site will produce both autoinjectors and pre-filled syringes – serving its pipeline and portfolio.
PharmaShots
Aug 21, 2026, 10:30 AM
Rein Therapeutics’ LTI-03 Secures the US FDA Fast Track Designation for Idiopathic Pulmonary Fibrosis
Shots: Ref: Rein Therapeutics | Image: Rein Therapeutics | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect@pharmashots.com The post Rein Therapeutics’ LTI-03 Secures the US FDA Fast Track Designation for Idiopathic Pulmonary Fibrosis appeared first on PharmaShots.
Pharma Tech
Aug 21, 2026, 9:52 AM
Eli Lilly’s weekly insulin jab Onswik set for NHS use if approved
Lilly’s drug could cut the number of injections each patient needs by 85%.
News
Latest industry coverage
Google News
Aug 22, 2026, 12:35 AM
Pharmacy Data into Policy Research… BRP Connect and Pharmaceutical Policy Research Institute Join Hands - 벤처스퀘어
Pharmacy Data into Policy Research… BRP Connect and Pharmaceutical Policy Research Institute Join Hands 벤처스퀘어
Google News
Aug 21, 2026, 11:10 PM
Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award - Law360
Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award Law360
Google News
Aug 21, 2026, 10:41 PM
Triethyl Citrate Market to Reach 260,000 Tonnes by 2035 as Phthalate Bans Drive Substitution in Food Contact and Medical Devices - IndexBox
Triethyl Citrate Market to Reach 260,000 Tonnes by 2035 as Phthalate Bans Drive Substitution in Food Contact and Medical Devices IndexBox
Google News
Aug 21, 2026, 9:13 PM
EVERSANA grows AI platform for life sciences - BioXconomy
EVERSANA grows AI platform for life sciences BioXconomy
Google News
Aug 21, 2026, 7:37 PM
How China’s biotech boom is bringing patients faster, more affordable drugs - BioXconomy
How China’s biotech boom is bringing patients faster, more affordable drugs BioXconomy
Google News
Aug 21, 2026, 7:28 PM
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK - Yahoo Finance
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK Yahoo Finance
Google News
Aug 21, 2026, 6:29 PM
Specialty pharmacies: What are they, and how do they affect drug costs? - Healthcare Brew
Specialty pharmacies: What are they, and how do they affect drug costs? Healthcare Brew
Google News
Aug 21, 2026, 6:15 PM
Alvotech, Lotus Ink Biosimilar Licensing and Commercialization Pact in US, Asia - Contract Pharma
Alvotech, Lotus Ink Biosimilar Licensing and Commercialization Pact in US, Asia Contract Pharma
Google News
Aug 21, 2026, 5:58 PM
Amplitude Therapeutics Partners with Eli Lilly | PharmExec - Pharmaceutical Executive
Amplitude Therapeutics Partners with Eli Lilly | PharmExec Pharmaceutical Executive
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer